• Possible link between depression and HHV-6 infection in childhood

    Serologic studies of several herpesviruses find that only HHV-6 may be linked to depression.

  • Reactivation of latent herpesviruses and HERVS after mild COVID-19

    Findings are accentuated in people with myalgic encephalomyelitis/chronic fatigue syndrome.

  • Virus specific T cell infusions show promise for preventing HHV-6B reactivation in transplant patients

    Review highlights the importance of cell mediated immunity and the limitations of antivirals, vaccines and immunoglobulin therapy for HHV-6, VZV and HSV.

  • Artesunate compares favorably to herpesvirus antivirals in suppressing HHV-6 and HHV-7

    Non-randomized study finds somewhat more potent reduction of virus in leucocytes over several months of treatment.

Newsletter | About Us | Contact Us | Donate | Repository

HHV-6 Foundation | HHV-6 Disease Information for Patients, Clinicians, and Researchers | Apply for a Grant Navigation
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter

Latest CNS Disease Articles

View Post

EBV and HHV-6 plasma viremia is infrequent at Day 7 during acute COVID-19

Other studies have suggested that reactivation of these viruses could theoretically contribute to a hyperinflammatory state or autoimmune disorders in acute COVID-19, but this study does not provide evidence of that.

View Post

Possible link between depression and HHV-6 infection in childhood

Serologic studies of several herpesviruses find that only HHV-6 may be linked to depression.

View Post

New seroepidemiological evidence that HHV-6 contributes to MS disease progression

Longitudinal study of people with a single initial episode of demyelination provides stronger evidence for HHV-6 than EBV in the pathogenesis of MS, but the evidence is not robust.

View Post

The presence of HHV-6 DNA in nasal swabs correlates with neurological symptoms in patients with severe COVID-19

40% of the patients with HHV-6 DNA had CNS symptoms, compared to 14.3% of the HHV-6 negative patients.

View Post

A relationship between human endogenous retroviruses and HHV-6A/B in multiple sclerosis patients

Significant positive correlations were found between HERV family proteins and antibodies to HHV-6A/B but not antibodies to EBV

View Post

CMV infection may diminish the risk of developing MS

Studies conducted on serum obtained before development of MS indicate possible protective role

View Post

Detection of HHV-6 miRNA in Multiple Sclerosis patients

HHV-6 miRNAs and antibodies were identified and significantly correlated with each other in serum and CSF of MS patients

View Post

Abnormal cytokine levels in children with epilepsy suggest link to inflammation

Unique pathways and significantly elevated cytokines were associated with a small cohort of pediatric seizure patients.

View Post

Imunocompromised patients with HHV-6 encephalitis have a ratio of CSF/blood viral load >1, whereas children with encephalitis due to primary infection have ratios of <1

Immunocompetent cases are typically children experiencing primary infection with high viral loads in the blood; cases in the immunocompromised typically involve reactivation in the brain tissue, with lower viral loads in the periphery

View Post

HHV-6 encephalitis can occur in CAR T-cell therapy and biologic immunotherapy

As with chemotherapy, immunotherapies for cancer can lead to HHV-6 encephalitis

View Post

Large serologic study incriminates both EBV and HHV-6A as triggers of multiple sclerosis

HHV-6A infection at any age, and EBV infection after age 20, were found to be significant risk factors

View Post

HHV-6 accounted for 5% of all herpetic viral encephalitis in immunocompetent Mexican patients

Psychiatric disorders were the most common prodomal symptom (58%) and this was significantly different from patients with non-herpesvirus encephalitis.

View Post

A review of the role of HHV-6A in multiple sclerosis and HHV-6B in epilepsy

Neuroscientists at Karolinska Institute in Sweden summarized the growing literature linking HHV-6A/B to both illnesses.

View Post

HHV-6 DNA found in spinal fluid of 8% of patients with aseptic meningitis

Multiplex testing for the causative agents of aseptic meningitis in Saudi Arabia identifies possible etiologic role for HHV-6

View Post

No HHV-6 DNA found in the spinal fluid of immunocompetent adults evaluated for limbic encephalitis

While HHV-6B is well known to cause limbic encephalitis in transplant patients, it does not appear to play a role in other forms of limbic encephalitis.

  • Page 2 of 6
  • ←
  • 1
  • 2
  • 3
  • ...
  • 6
  • →

Clinical News

  • Alzheimer’s Disease
  • Animal Models
  • Autoimmune Disease
  • Cancer
  • iciHHV-6
  • CNS Disease
  • COVID-19 / HHV-6 Reactivation
  • Drug Hypersensitivity
  • Encephalitis & Encephalopathy
  • Endocrine Conditions
  • Epilepsy and Seizures
  • Gastrointestinal
  • Genes
  • Heart Disease
  • Hematological Disorders
  • HIV/AIDS Progression
  • Immunity & Immunotherapy
  • Infertility & Miscarriage
  • Kidney Disease
  • Liver Disease
  • Lung Disease
  • Lymphadenopathy & Fever
  • ME/CFS
  • Multiple Sclerosis
  • Rash & Roseola
  • Transplant Complications
  • Treatments – Adoptive T cell
  • Treatments – Alternative
  • Treatments – Antiviral
  • Treatments – Immune Stimulant

About HHV-6

  • What Is HHV-6?
  • What is Inherited Chromosomally Integrated HHV-6
  • HHV-6 Repository of Reagents
  • HHV-6A/B Testing
  • HHV-6 Treatment

SUBSCRIBE TO OUR NEWSLETTER

ABOUT THE HHV-6 FOUNDATION

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B.

The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge.

Read More

HHV-6 Foundation | 1482 East Valley Road, Suite 619 | Santa Barbara, CA, 93108 | Toll Free: (888) 530-6726


Copyright ©2004-2022 HHV-6 FOUNDATION


WEB DESIGN AND DEVELOPMENT BY INSTYLE TECHNOLOGIES
  • Home
  • About
  • Conditions
  • Clinicians
  • Testing
  • Research
  • Repository
  • Patients
  • Treatment
  • News & Blog
  • Donate
  • Contact Us
  • Cart
  • Checkout
  • Privacy Policy
  • Terms of Use